The Role of New Viral Biomarkers in Chronic Hepatitis B: Ready to Use in the Clinical Practice?

Simple item page
dc.contributor.authorYapali, Suna
dc.date.accessioned2023-02-21T12:32:17Z
dc.date.available2023-02-21T12:32:17Z
dc.date.issued2018-01-01
dc.description.abstractRecent advances have been made to develop and improve the serologic and molecular virologic tools for the diagnosis and optimal management of chronic hepatitis B (CHB) infection. Several biomarkers associated with the natural course of chronic hepatitis B infection virus (HBV) and the efficacy of antiviral treatment have been defined. This article reviews the impact of hepatitis B surface antigen, hepatitis B core-related antigen and HBV RNA on the natural history, treatment response and outcomes of CHB infection.
dc.description.issue2
dc.description.issueAUG
dc.description.pages57-60
dc.description.volume24
dc.identifier.doi10.4274/vhd.2018.0012
dc.identifier.urihttps://hdl.handle.net/11443/951
dc.identifier.urihttp://dx.doi.org/10.4274/vhd.2018.0012
dc.identifier.wosWOS:000441968900006
dc.publisherGALENOS YAYINCILIK
dc.relation.ispartofVIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
dc.subjectHepatitis B surface antigen
dc.subjecthepatitis B core-related antigen
dc.subjecthepatitis B virus RNA
dc.titleThe Role of New Viral Biomarkers in Chronic Hepatitis B: Ready to Use in the Clinical Practice?
dc.typeArticle

Files

Collections

WOS